Khyber Medical University Journal-KMUJ, published by KHYBER MEDICAL UNIVERSITY, serves as a vital platform for the dissemination of research in the fields of Medicine, Dentistry, and Health Professions, among others. Established as an Open Access journal since 2009, KMUJ enables greater accessibility to cutting-edge research, fostering collaboration and knowledge exchange within the medical community. With its headquarters in Kohat, Khyber Pakhtunkhwa, Pakistan, the journal caters to a diverse audience by offering insights into various aspects of healthcare, emphasizing innovation and evidence-based practices. Despite its current Q4 ranking in multiple categories, KMUJ is dedicated to enhancing its impact through rigorous peer-reviewed content, aiming to elevate research standards within the region. As it converges from 2019 to 2024, KMUJ strives to contribute significantly to emerging topics in pharmacology, toxicology, and public health, making it an essential resource for researchers, professionals, and students committed to advancing medical science.

Functional Foods in Health and Disease is a respected peer-reviewed journal published by FUNCTIONAL FOOD CENTER INC, dedicated to advancing research in the fields of biochemistry, food science, medicine, and nutrition. Since its inception in 2011, this journal has provided a platform for innovative studies that connect the impact of functional foods on health and disease outcomes. With a focus on interdisciplinary research, it aims to disseminate knowledge that enhances the understanding of how specific food components can influence health and well-being. The journal is indexed with an ISSN of 2160-3855 and annually ranked in several categories, including Q4 in Biochemistry and Q3 in Food Science, Medicine, and Nutrition and Dietetics for 2023. As an open access publication, it ensures that research is widely accessible, which is crucial for fostering collaboration and discussion within the scientific community. This journal is a vital resource for researchers, practitioners, and students seeking to explore the dynamic role of functional foods in health promotion and disease prevention.

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

Reviews on Recent Clinical Trials, published by Bentham Science Publishers Ltd, is a distinguished journal in the medical and pharmacological fields, assessing the latest advancements in clinical research since its inception in 2006. With a focus on integrating multidisciplinary approaches to evaluating clinical trial methodologies, the journal caters to a diverse audience of researchers, professionals, and students keen on enhancing their knowledge and understanding of innovative therapeutic strategies and drug developments. Notably positioned in the Q3 quartile as ranked by Scopus for both 'Medicine (miscellaneous)' and 'Pharmacology', the journal illustrates a growing academic influence, evidenced by its Scopus rankings—holding a commendable 72nd percentile in general medicine and a 33rd percentile in pharmacology. While the journal is not open access, it remains committed to disseminating high-quality, peer-reviewed content that drives forward the conversation in clinical research. For those interested in staying abreast of novel findings and comprehensive reviews within the clinical trial landscape, Reviews on Recent Clinical Trials stands out as an essential resource.

BMJ Open is a distinguished open access journal published by the BMJ Publishing Group, dedicated to advancing the field of medicine through the dissemination of high-quality research. Since its inception in 2011, this journal has positioned itself as a pivotal platform in the medical arena, presently classified in the Q1 category of Medicine (Miscellaneous) for 2023, reflecting its commitment to excellence as evidenced by its Scopus ranking of #117 out of 636, placing it in the top 81st percentile. With its open access model, BMJ Open ensures that research is readily available to a global audience, promoting collaboration and knowledge sharing among researchers, healthcare professionals, and students alike. Located in London, UK, the journal is committed to featuring innovative research that informs clinical practice, public health, and healthcare policy, making it an essential resource for anyone engaged in medical research and practice.

Complementary Therapies in Clinical Practice is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of complementary and alternative medicine. With an impressive impact factor placing it in the Q1 category for its field and a Scopus rank of 16 out of 105, it serves as a vital platform for sharing high-quality research and clinical insights. Established in 2005 and continuing through 2024, the journal is committed to disseminating evidence-based practices that enhance patient care and safety. Although it does not offer open access, the journal remains integral to researchers, clinicians, and students striving to integrate complementary therapies within conventional healthcare frameworks. Based in the United Kingdom, the journal not only promotes scholarly discourse but also fosters collaboration across an international community of practitioners dedicated to innovative therapeutic approaches.

PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

The International Journal of Biostatistics, published by Walter de Gruyter GmbH, stands as a critical platform for advancements in the fields of biostatistics and applied statistics in medicine. With an ISSN of 2194-573X and an E-ISSN of 1557-4679, this journal has gained recognition for its rigorous peer-reviewed articles that bridge theoretical statistics and its practical applications in health sciences, maintaining a commendable Q2 quartile ranking in both Medicine and Statistics categories as of 2023. Hosted in Germany, the journal's pivotal role lies in disseminating innovative research findings that guide public health decisions and inform healthcare policy, thus appealing to a diverse readership including researchers, healthcare professionals, and students. Although the journal operates under a subscription model, it remains committed to providing valuable insights into the statistical methods that support evidence-based medicine and improve health outcomes globally. For those engaged in the evolving landscape of biostatistics, the International Journal of Biostatistics serves as an indispensable resource through its comprehensive coverage from 2005 to 2024.

The Iranian Journal of Psychiatry and Clinical Psychology, a distinguished publication by IRAN UNIV MEDICAL SCIENCES, serves as a vital platform for the dissemination of research and advancements in the fields of clinical psychology and psychiatry. With its ISSN 1735-4315 and E-ISSN 2228-7515, the journal reaches a diverse audience of researchers, practitioners, and students, specifically in Iran and the broader international community. This open access journal, based in Tehran, facilitates knowledge sharing through its commitment to exploring contemporary issues and emerging trends from 2018 to 2024. Recognized for its significant contributions, it has achieved a Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health categories in 2023, alongside Scopus rankings that place it within the lower quartiles of its respective fields. The journal's aim is to foster a deeper understanding of mental health challenges, promote evidence-based practices, and enhance the quality of mental health care, making it an essential resource for advancing academic and clinical excellence.